A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma

Surgical Neurology

Volumn 60, Issue 4, 2003, Pages 321-324

  Takeshima, Hideo ^a   Kuratsu, Jun Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Central nervous system; Cerebrospinal fluid; Dissemination; Germ cell tumor; S kit; Tumor marker

Indexed keywords

STEM CELL FACTOR; TUMOR MARKER;

BRAIN METASTASIS; CELL SURFACE; CEREBROSPINAL FLUID ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GERM CELL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SYNCYTIOTROPHOBLAST; TARGET CELL DESTRUCTION; TISSUE SECTION;

EID: 0141737843     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(03)00430-0     Document Type: Review

References (27)

1. Balmaceda C., Heller G., Rosenblum M., et al. Chemotherapy without irradiation - a novel approach for newly diagnosed CNS germ cell tumors results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study . J Clin Oncol. 14:1996;2908-2915.
2. Bokemeyer C., Kuczyk M.A., Dunn T., et al. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol. 122:1996;301-306.
3. Heaney M.L., Golde D.W. Soluble cytokine receptors. Blood. 87:1996;847-857.
4. Heinrich M.C., Blanke C.D., Druker B.J., Corless C.L. Inhibition of KIT tyrosine kinase activity a novel molecular approach to the treatment of KIT-positive malignancies . J Clin Oncol. 20:2002;1692-1703.
5. Hines S.J., Organ C., Kornstein M.J., Krystal G.W. Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ. 6:1995;769-779.
6. Hoffman H.J., Otsubo H., Hendrick E.B., et al. Intracranial germ-cell tumors in children. J Neurosurg. 74:1991;545-551.
7. Jennings M.T., Gelman R., Hochberg F. Intracranial germ-cell tumors natural history and pathogenesis . J Neurosurg. 63:1985;155-167.
8. Kawakita M., Yonemura Y., Miyake H., et al. Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. Br J Haematol. 91:1995;23-29.
9. Kiltie A.E., Gattamaneni H.R. Survival and quality of life of paediatric intracranial germ cell tumour patients treated at the Christie Hospital, 1972-1993. Med Pediatr Oncol. 25:1995;450-456.
10. Lassam N., Bickford S. Loss of c-kit expression in cultured melanoma cells. Oncogene. 7:1992;51-56.
11. Lev S., Yarden Y., Givol D. A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. J Biol Chem. 267:1992; 10866-10873.
12. Matsuda R., Takahashi T., Nakamura S., et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol. 142:1993;339-346.
13. Matsui Y., Toksoz D., Nishikawa S., Williams D., Zsebo K., Hogan B.L. Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature. 353:1991;750-752.
14. Matsutani M., Ushio Y., Abe H., et al. Combined chemotherapy and radiation therapy for central nervous system germ cell tumor preliminary results of a phase II study of the Japanese Pedriatric Brain Tumor Study Group . Neurosurg Focus. 5:1998;1-5.
15. Miyanohara O., Takeshima H., Kaji M., et al. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors. J Neurosurg. 97:2002;177-183.
16. Packer A.I., Besmer P., Bachvarova R.F. Kit ligand mediates survival of type A spermatogonia and dividing spermatocytes in postnatal mouse testes. Mol Reprod Dev. 42:1995;303-310.
17. Pesce M., Farrace M.G., Piacentini M., Dolci S., De Felici M. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development. 118:1993;1089-1094.
18. Pietsch T., Nicotra M.R., Fraioli R., Wolf H.K., Mottolese M., Natali P.G. Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas. Int J Cancer. 75:1998;171-175.
19. Sawamura Y., de Tribolet N., Ishii N., Abe H. Management of primary intracranial germinomas diagnostic surgery or radical resection? J Neurosurg. 87:1997;262-266.
20. Sawamura Y., Shirato H., Ikeda J., et al. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg. 88:1998;66-72.
21. Sekido Y., Obata Y., Ueda R., et al. Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. Cancer Res. 51:1991;2416-2419.
22. Shirato H., Nishio M., Sawamura Y., et al. Analysis of long-term treatment of intracranial germinoma. Int J Radiat Oncol Biol Phys. 37:1997;511-515.
23. Tada M. Tumor markers. Sawamura Y., Shirato H., Tribilet N. Intracranial Germ Cell Tumors. 1998;146-153 Springer-Verlag, Wien.
24. Ushio Y., Kochi M., Kuratsu J., Itoyama Y., Marubayashi T. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. J Neurosurg. 90:1999;133-137.
25. Wara W.M., Fellows C.F., Sheline G.E., Wilson C.B., Townsend J.J. Radiation therapy for pineal tumors and suprasellar germinomas. Radiology. 124:1977;221-223.
26. Witte O.N. Steel locus defines new multipotent growth factor. Cell. 63:1990;5-6.
27. Yarden Y., Kuang W.J., Yang-Feng T., et al. Human proto-oncogene c-kit a new cell surface receptor tyrosine kinase for an unidentified ligand . Embo J. 6:1987;3341-3351.